Zackary D Vaughn, MD
Orthopedic Surgery · Redwood City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 4 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
18 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Vaughn’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A93305 · Current
Licensed to practise in California · since 2005 · expires 2027-09-30 · Saint Louis University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$133,305
Medicare paid this office $133,305 for 363 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 165 | $23,592 | $143 |
| Return visit (30+ min) | 165 | $23,321 | $114 |
| Repair of shoulder rotator cuff using an endoscope | 20 | $19,383 | $969 |
| Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 13 | $10,180 | None |
| Short return visit (20+ min) | 92 | $9,116 | $83 |
See all 10 services
| New patient visit (45+ min) | 165 | $23,592 | $143 |
| Return visit (30+ min) | 165 | $23,321 | $114 |
| Repair of shoulder rotator cuff using an endoscope | 20 | $19,383 | $969 |
| Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 13 | $10,180 | None |
| Short return visit (20+ min) | 92 | $9,116 | $83 |
| Aspiration and/or injection of fluid from large joint | 97 | $9,087 | $68 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 15 | $8,887 | None |
| Removal of both knee cartilages using an endoscope | 11 | $5,870 | $489 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 21 | $3,116 | $148 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 84 | $388 | None |
Procedures Medicare counted
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 50 | More than 99% of doctors who do this |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 62 | More than 90% of doctors who do this |
Who their Medicare patients are
363 Original Medicare patients in 2024. Average age 72 · Under 65 6% · 85 and older 6% · Women 60% · Also on Medicaid 10% · Health risk score 0.86. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 62% · Coronary heart disease 26% · Diabetes 22% · Depression 17% · Cancer 13% · Atrial fibrillation 11% · Chronic kidney disease 10% · Heart failure 9% · Stroke 8% · COPD 7% · Dementia 4%.
The office billed $967,348, Medicare allowed $175,974 and paid $133,305; for 1,982 services of 29 kinds; $20,480 of it was for drugs given in the office and $112,825 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 363 | 1,982 | 72 | 0.86 | $967,348 | $133,305 |
| 2023 | 322 | 2,366 | 73 | 0.83 | $1,096,544 | $111,304 |
| 2022 | 304 | 3,561 | 72 | 0.91 | $1,324,438 | $130,886 |
| 2021 | 294 | 3,706 | 72 | 0.96 | $1,113,490 | $128,445 |
| 2020 | 256 | 3,731 | 71 | 0.93 | $1,334,019 | $112,772 |
| 2019 | 294 | 3,925 | 72 | 0.89 | $1,167,666 | $110,849 |
| 2018 | 237 | 8,834 | 71 | 0.96 | $1,009,459 | $83,891 |
| 2017 | 227 | 8,984 | 71 | 0.97 | $763,104 | $80,610 |
| 2016 | 201 | 2,293 | 69 | 1.07 | $476,091 | $61,347 |
| 2015 | 183 | 406 | 72 | 0.94 | $424,030 | $60,733 |
| 2014 | 138 | 283 | 72 | 0.82 | $233,009 | $33,478 |
| 2013 | 141 | 274 | 72 | 0.94 | $498,915 | $46,411 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 152 | $22,528 | $117 |
| New patient visit (45+ min) | 154 | $21,698 | $141 |
| Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 16 | $13,557 | None |
| Repair of shoulder rotator cuff using an endoscope | 12 | $11,872 | $989 |
| Aspiration and/or injection of fluid from large joint | 91 | $8,823 | $68 |
| Short return visit (20+ min) | 76 | $8,067 | $84 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 12 | $5,939 | None |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 12 | $1,831 | $153 |
| Telehealth originating site facility fee | 19 | $455 | $21 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 71 | $398 | None |
2022: 11 services
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 20 | $25,613 | None |
| Return visit (30+ min) | 147 | $20,389 | $119 |
| New patient visit (45+ min) | 136 | $18,462 | $136 |
| Repair of shoulder rotator cuff using an endoscope | 16 | $17,705 | $984 |
| Aspiration and/or injection of fluid from large joint | 101 | $9,720 | $67 |
| Short return visit (20+ min) | 84 | $9,591 | $84 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 15 | $2,283 | $152 |
| Telehealth originating site facility fee | 31 | $633 | $20 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 86 | $524 | None |
| Injection, ropivacaine hydrochloride, 1 mg | 50 | $88 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 14 | $2 | None |
2021: 8 services
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 16 | $28,281 | None |
| Return visit (30+ min) | 164 | $24,239 | $121 |
| New patient visit (45+ min) | 128 | $19,126 | $149 |
| Short return visit (20+ min) | 68 | $8,236 | $83 |
| Aspiration and/or injection of fluid from large joint | 77 | $7,025 | $64 |
| Telehealth originating site facility fee | 23 | $519 | $19 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 59 | $350 | None |
| Injection, ropivacaine hydrochloride, 1 mg | 59 | $113 | None |
2020: 14 services
| Repair of shoulder rotator cuff using an endoscope | 22 | $23,739 | $989 |
| Short return visit (20+ min) | 165 | $16,309 | $68 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 16 | $11,061 | None |
| Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 11 | $10,207 | None |
| New patient visit (30+ min) | 103 | $9,999 | $97 |
| Removal of joint lining from multiple knee joint compartments using an endoscope | 11 | $7,262 | $605 |
| Aspiration and/or injection of fluid from large joint | 82 | $6,708 | $62 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 19 | $3,326 | $158 |
| Return visit (30+ min) | 29 | $2,532 | $87 |
| Removal of extensive shoulder joint tissue using an endoscope | 13 | $2,058 | $147 |
| Removal of knee cartilage using an endoscope | 11 | $1,355 | $123 |
| Telehealth originating site facility fee | 27 | $679 | $21 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 58 | $376 | None |
| Injection, ropivacaine hydrochloride, 1 mg | 60 | $108 | None |
2019: 10 services
| Repair of shoulder rotator cuff using an endoscope | 17 | $16,594 | $976 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 17 | $16,361 | None |
| Short return visit (20+ min) | 156 | $16,297 | $65 |
| New patient visit (30+ min) | 131 | $12,437 | $95 |
| Removal of both knee cartilages using an endoscope | 12 | $6,552 | $504 |
| Aspiration and/or injection of fluid from large joint | 92 | $6,526 | $55 |
| Return visit (30+ min) | 58 | $5,680 | $98 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 16 | $2,497 | $156 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 72 | $503 | None |
| Injection, ropivacaine hydrochloride, 1 mg | 76 | $146 | None |
2018: 9 services
| Repair of shoulder rotator cuff using an endoscope | 14 | $13,460 | $961 |
| Short return visit (20+ min) | 135 | $13,103 | $64 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 15 | $11,459 | None |
| New patient visit (30+ min) | 111 | $10,098 | $91 |
| Aspiration and/or injection of fluid from large joint | 76 | $6,604 | $59 |
| Return visit (30+ min) | 32 | $3,161 | $99 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 16 | $2,364 | $148 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 61 | $581 | None |
| Injection, ropivacaine hydrochloride, 1 mg | 65 | $456 | None |
2017: 9 services
| Repair of shoulder rotator cuff using an endoscope | 16 | $15,461 | $966 |
| Short return visit (20+ min) | 131 | $13,193 | $64 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 12 | $10,123 | None |
| New patient visit (30+ min) | 102 | $9,609 | $94 |
| Aspiration and/or injection of fluid from large joint | 54 | $4,745 | $54 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 18 | $2,793 | $155 |
| Return visit (30+ min) | 23 | $2,137 | $93 |
| Injection, ropivacaine hydrochloride, 1 mg | 45 | $451 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 45 | $450 | None |
2016: 6 services
| Short return visit (20+ min) | 109 | $12,059 | $64 |
| New patient visit (30+ min) | 92 | $8,419 | $92 |
| Aspiration and/or injection of fluid from large joint | 47 | $3,960 | $49 |
| Return visit (30+ min) | 21 | $2,004 | $95 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 15 | $111 | None |
| Injection, ropivacaine hydrochloride, 1 mg | 15 | $101 | None |
2015: 3 services
| Short return visit (20+ min) | 104 | $11,086 | $64 |
| New patient visit (30+ min) | 96 | $9,294 | $97 |
| Aspiration and/or injection of fluid from large joint | 32 | $2,462 | $50 |
2014: 3 services
| Short return visit (20+ min) | 86 | $8,636 | $65 |
| New patient visit (30+ min) | 73 | $6,106 | $84 |
| Aspiration and/or injection of fluid from large joint | 28 | $1,530 | $44 |
2013: 4 services
| Short return visit (20+ min) | 58 | $5,888 | $64 |
| New patient visit (30+ min) | 57 | $5,586 | $98 |
| Replacement of knee joint, both sides of knee | 11 | $2,436 | $221 |
| Aspiration and/or injection of fluid from large joint | 16 | $1,063 | $51 |
Drugs they prescribed that Part D paid
$1,131
Pharmacies billed $1,131 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
69 generic and 0 brand-name prescriptions · $1,131 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Celecoxib | 23 | $891 | $23 |
Year by year
| 2024 | 69 | 47 | None | 0% | $1,131 |
| 2023 | 47 | 31 | None | 0% | $831 |
| 2022 | 40 | 27 | None | 0% | $760 |
| 2021 | 65 | 35 | None | 0% | $1,552 |
| 2020 | 83 | 42 | None | 0% | $1,460 |
| 2019 | 94 | 40 | 14% (13) | None | $1,781 |
| 2018 | 68 | 27 | 16% (11) | None | $1,504 |
| 2017 | 65 | 32 | 31% (20) | None | $1,621 |
| 2016 | 59 | 32 | 39% (23) | None | $3,625 |
| 2015 | 75 | 39 | 33% (25) | 41% | $8,801 |
| 2014 | 93 | 46 | 42% (39) | 18% | $8,449 |
| 2013 | 100 | 35 | 36% (36) | 18% | $5,850 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Celecoxib | 21 | $681 | $32 |
2022: 1 drug
| Celecoxib | 11 | $593 | $54 |
2021: 3 drugs
| Celecoxib | 16 | $906 | $57 |
| Diclofenac | 16 | $405 | $25 |
| Meloxicam | 11 | $58 | $5 |
2020: 2 drugs
| Diclofenac | 24 | $821 | $34 |
| Meloxicam | 34 | $123 | $4 |
2019: 3 drugs
| Diclofenac | 20 | $697 | $35 |
| Celecoxib | 13 | $538 | $41 |
| Meloxicam | 27 | $79 | $3 |
2018: 2 drugs
| Diclofenac | 18 | $500 | $28 |
| Meloxicam | 17 | $25 | $1 |
2017: 2 drugs
| Oxycodone-Acetaminophen | 11 | $391 | $36 |
| Diclofenac | 14 | $338 | $24 |
2016: 1 drug
| Celecoxib | 12 | $2,777 | $231 |
2015: 1 drug
| Celecoxib | 28 | $6,753 | $241 |
2014: 3 drugs
| Celebrex | 14 | $4,936 | $353 |
| Diclofenac | 20 | $354 | $18 |
| Hydrocodone-Acetaminophen | 25 | $341 | $14 |
2013: 3 drugs
| Celebrex | 13 | $4,038 | $311 |
| Diclofenac | 28 | $677 | $24 |
| Hydrocodone-Acetaminophen | 30 | $287 | $10 |
Money from drug and device companies
$104 in 2025
| 2025 | 1 | 1 | None | $104 |
| 2022 | 3 | 8 | None | $4,183 |
| 2021 | 1 | 2 | $3,150 | $3,163 |
| 2020 | 2 | 2 | None | $667 |
| 2019 | 3 | 3 | $125 | $362 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Djo | Donjoy | $104 | 1 payment
|
See the published payment
| Djo | Meals · 2025-03-13 | Donjoy | $104 |
See earlier years (2022, 2021, 2020, 2019)
2022: $4,183
| Evolution Surgical | None | $2,726 | 5 payments
|
| Arthrex | None | $1,224 | 2 payments
|
| Djo | Procare | $233 | 1 payment
|
2021: $3,163
| Evolution Surgical | None | $3,163 | 2 payments
|
2020: $667
| Evolution Surgical | None | $594 | 1 payment
|
| Arthrex | Knee & Hip Implants Suspensory Fixation Other | $73 | 1 payment
|
2019: $362
| Smith+Nephew | Novostitch | $125 | 1 payment
|
| Anika Therapeutics | Tactoset | $119 | 1 payment
|
| Zimmer Biomet Holdings | Maxbraid Boxed Sutures | $118 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1649305772
- Licence
- CA A93305California A93305: Current · expires 2027-09-30
- Trained
- Saint Louis University School of Medicine, 2004
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 237 Cypress Point Dr, Mountain View, CA, 94043
- NPI first listed
- 2007-02-22
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.